Professional Seasonal Analysis for Trading

Enlivex Therapeutics Ltd. - Ordinary Shares (ENLV)

Seasonality Analysis

Stocks 12 Years Analyzed

Enlivex Therapeutics Ltd. - Ordinary Shares Annual Seasonality Statistics

-22.72%
Avg Annual Return
40.4%
Avg Monthly Win Rate
4/12
Positive Months
12
Years Analyzed

Enlivex Therapeutics Ltd. - Ordinary Shares Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January BEST 9.74%
58%
Moderate
February -1.13%
50%
Weak
March WORST -9.68%
25%
Very Weak
April -8.56%
33%
Very Weak
May -7.33%
27%
Very Weak
June 8.89%
45%
Weak
July -0.92%
45%
Weak
August 6.36%
42%
Weak
September -5.30%
42%
Weak
October -9.31%
42%
Weak
November 1.65%
42%
Weak
December -7.13%
33%
Very Weak

Enlivex Therapeutics Ltd. - Ordinary Shares 2026 vs Historical Pattern

Current Position
12.83
Historical Avg Position
32.88
Deviation
-20.05
Performance
Significantly Below Average

Enlivex Therapeutics Ltd. - Ordinary Shares Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for ENLV with overlay patterns, custom date ranges, and more.

Create Free Account

Enlivex Therapeutics Ltd. - Ordinary Shares Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Enlivex Therapeutics Ltd. - Ordinary Shares Seasonal Historical Performance

Historical Performance

See historical average returns for ENLV across multiple timeframes.

Create Free Account

About Enlivex Therapeutics Ltd. - Ordinary Shares (ENLV) Seasonality

Enlivex Therapeutics Ltd. - Ordinary Shares (ENLV) has been analyzed using 12 years of historical data to identify seasonal patterns. Classified under Stocks, Enlivex Therapeutics Ltd. - Ordinary Shares shows distinct seasonal tendencies based on historical data.

The strongest month for Enlivex Therapeutics Ltd. - Ordinary Shares is historically January, with an average return of 9.74% and a win rate of 58%. Conversely, March tends to be the weakest month, averaging -9.68% return.

Looking at the full calendar year, Enlivex Therapeutics Ltd. - Ordinary Shares has an average annual return of -22.72% with an overall monthly win rate of 40.4%. Out of 12 months, 4 typically show positive average returns.

The seasonal pattern for Enlivex Therapeutics Ltd. - Ordinary Shares has a consistency score of 61.1 (Good), based on 13 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Enlivex Therapeutics Ltd. - Ordinary Shares Seasonality FAQ

What is the best month to buy Enlivex Therapeutics Ltd. - Ordinary Shares (ENLV)?

Historically, January has been the best month for Enlivex Therapeutics Ltd. - Ordinary Shares, with an average return of 9.74% and a win rate of 58%. However, past performance does not guarantee future results.

What is the worst month for Enlivex Therapeutics Ltd. - Ordinary Shares (ENLV)?

Based on historical data, March has been the weakest month for Enlivex Therapeutics Ltd. - Ordinary Shares, with an average return of -9.68%. This is a historical observation and does not guarantee future results.

How reliable is ENLV seasonality data?

The seasonality analysis for Enlivex Therapeutics Ltd. - Ordinary Shares is based on 12 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Enlivex Therapeutics Ltd. - Ordinary Shares seasonality in my trading?

Use Enlivex Therapeutics Ltd. - Ordinary Shares (ENLV) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.